Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

MLA

Lovell DJ, et al. “Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis.” New England Journal of Medicine, vol. 359, no. 8, Aug. 2008, pp. 810–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=105703381&authtype=sso&custid=ns315887.

APA

Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz H, & Olson NY. (2008). Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. New England Journal of Medicine, 359(8), 810–820.

Chicago

Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, et al. 2008. “Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis.” New England Journal of Medicine 359 (8): 810–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=105703381&authtype=sso&custid=ns315887.